Nina Becher-Boveleth Selected Research

7-bromoindirubin-3'-oxime

1/2015

Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nina Becher-Boveleth Research Topics

Disease

3	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 01/2015
2	Lymphoma (Lymphomas) 10/2022 - 01/2017
2	Neoplasms (Cancer) 01/2017 - 07/2015
2	Anaplastic Thyroid Carcinoma 01/2016 - 07/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022
1	Necrosis 07/2015

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2016 - 07/2015
1	Deoxyglucose (2 Deoxy D glucose)IBA 10/2022
1	MTOR InhibitorsIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	ABT-737IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	obatoclaxIBA 07/2015
1	7-bromoindirubin-3'-oximeIBA 01/2015
1	indirubinIBA 01/2015

Therapy/Procedure

2	Therapeutics 10/2022 - 07/2015